Search

Search Constraints

You searched for: Author/Creator Slager, Susan L.

Search Results

1. A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk. Issue 2 (1st October 2022)

2. A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts. (9th September 2016)

3. Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare. Issue 3 (13th December 2019)

4. Analysis of racial variations in disease characteristics, treatment patterns, and outcomes of patients with chronic lymphocytic leukemia. Issue 7 (24th April 2016)

5. Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era. Issue 8 (27th May 2021)

6. Aspirin and other nonsteroidal anti‐inflammatory drugs, statins and risk of non‐Hodgkin lymphoma. Issue 3 (8th March 2021)

7. Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL). Issue 7 (3rd July 2017)

8. Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre. (16th August 2018)

9. CD49d associates with nodal presentation and subsequent development of lymphadenopathy in patients with chronic lymphocytic leukaemia. (7th April 2017)

10. Combined ibrutinib and venetoclax for treatment of patients with ibrutinib‐resistant or double‐refractory chronic lymphocytic leukaemia. (16th July 2022)